Optimal ex vivo expansion of neutrophils from PBSC CD34+ cells by a combination of SCF, Flt3-L and G-CSF and its inhibition by further addition of TPO

Journal of Translational Medicine

Volumn 5, Issue , 2007, Pages

  Tura, Olga ^a   Barclay, G Robin ^a   Roddie, Huw ^b   Davies, John ^b   Turner, Marc L ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; STEM CELL FACTOR; SUPEROXIDE; THROMBOPOIETIN; CD34 ANTIGEN; FLT3 LIGAND PROTEIN; MEMBRANE PROTEIN; PEROXIDASE; UNCLASSIFIED DRUG;

ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CD34 SELECTION; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CELL STRUCTURE; CHEMOLUMINESCENCE; CONTROLLED STUDY; EX VIVO STUDY; GENE MUTATION; GRANULOCYTE; HUMAN; HUMAN CELL; MEGAKARYOCYTE; NEUTROPENIA; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL BLOOD STEM CELL; PHENOTYPE; RESPIRATORY BURST; STEM CELL MOBILIZATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; BLOOD; CELL DIVISION; DRUG EFFECT; HEMATOPOIESIS; METABOLISM; PHYSIOLOGY; STEM CELL;

ANTIGENS, CD34; CELL DIVISION; CYTOKINES; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HUMANS; MEMBRANE PROTEINS; NEUTROPHILS; PEROXIDASE; PLATELET TRANSFUSION; STEM CELL FACTOR; STEM CELLS;

EID: 37849035702     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-5-53     Document Type: Article

References (43)

1. Shpall EJ Jones RB Bearman SI Cagnoni PJ Nieto Y McNiece IK Peripheral blood stem cell transplantation in breast cancer Baillieres Best Pract Res Clin Haematol 1999, 12:219-232 11000995
2. McNiece I Briddell R Ex vivo expansion of hematopoietic progenitor cells and mature cells Exp Hematol 2001, 29:3-11 10.1016/S0301-472X(00)00610-X 11164100
3. Paquette R Dorshkind K Optimizing hematopoietic recovery following bone marrow transplantation J Clin Invest 2002, 109:1527-1528 151019 12070297 10.1172/JCI200215916
4. Heike T Nakahata T Ex vivo expansion of hematopoietic stem cells by cytokines Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2002, 1592:313-321 10.1016/S0167-4889(02)00324-5
5. McNiece I Ex vivo expansion of hematopoietic cells Exp Hematol 2004, 32:409-410 10.1016/j.exphem.2004.02.006 15145206
6. Despres D Flohr T Uppenkamp M Baldus M Hoffmann M Huber C Derigs HG CD34+ cell enrichment for autologous peripheral blood stem cell transplantation by use of the CliniMACs device J Hematother Stem Cell Res 2000, 9:557-564 10.1089/152581600419242 10982256
7. Ogura M Kagami Y Suzuki R Miura K Uehira K Kurokawa T Ito T Kinoshita T Emi N Morishima Y Kodera Y Ueda R Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies. Nagoya CD34+ PBSCT Study Group Cancer Chemother Pharmacol 1997, 40(Suppl):S51-S57 10.1007/s002800051062 9272135
8. Shpall EJ Jones RB Bearman SI Franklin WA Archer PG Curiel T Bitter M Claman HN Stemmer SM Purdy M. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment J Clin Oncol 1994, 12:28-36 7505806
9. Urbano-Ispizua A Solano C Brunet S de la RJ Odriozola J Zuazu J Figuera A Caballero D Martinez C Garcia J Sanz G Torrabadella M Alegre A Perez-Oteiza J Jurado M Oyonarte S Sierra J Garcia-Conde J Rozman C Allogeneic transplantation of purified CD34+ cells from peripheral blood: Spanish experience of 62 cases. Spanish Group of allo-PBT Bone Marrow Transplant 1998, 21(Suppl 3):S71-S74 9712500
10. McNiece I Jones R Bearman SI Cagnoni P Nieto Y Franklin W Ryder J Steele A Stoltz J Russell P McDermitt J Hogan C Murphy J Shpall EJ Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer Blood 2000, 96:3001-3007 11049977
11. Boiron JM Dazey B Cailliot C Launay B Attal M Mazurier F McNiece IK Ivanovic Z Caraux J Marit G Reiffers J Large-scale expansion and transplantation of CD34(+) hematopoietic cells: In vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity Transfusion 2006, 46:1934-1942 10.1111/j.1537-2995.2006.01001.x 17076849
12. Paquette RL Dergham ST Karpf E Wang HJ Slamon DJ Souza L Glaspy JA Ex vivo expanded unselected peripheral blood: Progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer Blood 2000, 96:2385-2390 11001888
13. Prince HM Simmons PJ Whitty G Wall DP Barber L Toner GC Seymour JF Richardson G Mrongovius R Haylock DN Improved haematopoietic recovery following transplantation with ex vivo-expanded mobilized blood cells Br J Haematol 2004, 126:536-545 10.1111/j.1365-2141.2004.05081.x 15287947
14. Reichle A Zaiss M Rothe G Schmitz G Andreesen R Autologous tandem transplantation: Almost complete reduction of neutropenic fever following the second transplantation by ex vivo expanded autologous myeloid postprogenitor cells Bone Marrow Transplant 2003, 32:299-305 10.1038/sj.bmt.1704126 12858202
15. Reiffers J Cailliot C Dazey B Attal M Caraux J Boiron JM Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells Lancet 1999, 354:1092-1093 10.1016/ S0140-6736(99)03113-X 10509503
16. Briones MA Josephson CD Hillyer CD Granulocyte transfusion: Revisited Curr Hematol Rep 2003, 2:522-527 14561398
17. Price TH Granulocyte colony-stimulating factor-mobilized granulocyte concentrate transfusions Curr Opin Hematol 1998, 5:391-395 10.1097/ 00062752-199811000-00007 9814645
18. Strauss RG Rebirth of granulocyte transfusions: Should it involve pediatric oncology and transplant patients? J Pediatr Hematol Oncol 1999, 21:475-478 10.1097/00043426-199911000-00007 10598657
19. Yeghen T Devereux S Granulocyte transfusion: A review Vox Sang 2001, 81:87-92 10.1046/j.1423-0410.2001.00090.x 11555467
20. Bertolini F Battaglia M Pedrazzoli P Da Prada GA Lanza A Soligo D Caneva L Sarina B Murphy S Thomas T della Cuna GR Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients Blood 1997, 89:2679-2688 9108385
21. Decaudin D Vantelon JM Bourhis JH Farace F Bonnet ML Guillier M Greissenger N Marracho MC Assari S Bennaceur AL Nemati F Michon J Turhan AG Boccaccio C Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma Bone Marrow Transplant 2004, 34:1089-1093 10.1038/sj.bmt.1704675 15489877
22. Scheding S Bergmannn M Rathke G Vogel W Brugger W Kanz L Additional transplantation of ex vivo generated megakaryocytic cells after high-dose chemotherapy Haematologica 2004, 89:630-631 15136238
23. Sutherland DR Anderson L Keeney M Nayar R Chin-Yee I The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering J Hematother 1996, 5:213-226 8817388
24. De Novo Software http://www.denovosoftware.com 2007 http://www.denovosoftware.com
25. Hino M Suzuki K Yamane T Sakai N Kubota H Koh KR Ohta K Hato F Kitagawa S Tatsumi N Ex vivo expansion of mature human neutrophils with normal functions from purified peripheral blood CD34+ haematopoietic progenitor cells Br J Haematol 2000, 109:314-321 10.1046/j.1365-2141.2000.02054.x 10848817
26. Scheding S Meister B Buhring HJ Baum CM Mc Kearn JP Bock T Kanz L Brugger W Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells Exp Hematol 2000, 28:460-470 10.1016/S0301-472X(00)00133-8 10781904
27. De Bruyn C Delforge A Bernier M Bron D Ex vivo expansion of neutrophil precursor cells from fresh and cryopreserved cord blood cells Cytotherapy 2003, 5:87-98 10.1080/14653240310000119 12745585
28. Haylock DN To LB Dowse TL Juttner CA Simmons PJ Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage Blood 1992, 80:1405-1412 1381625
29. Holyoake TL Alcorn MJ Richmond L Farrell E Pearson C Green R Dunlop DJ Fitzsimons E Pragnell IB Franklin IM CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens Bone Marrow Transplant 1997, 19:1095-1101 10.1038/sj.bmt.1700799 9193752
30. Piacibello W Sanavio F Garetto L Severino A Dane A Gammaitoni L Aglietta M Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation Leukemia 1998, 12:718-727 10.1038/ sj.leu.2401003 9593270
31. Robinson S Niu T de Lima M Ng J Yang H McMannis J Karandish S Sadeghi T Fu P del Angel M O'Connor S Champlin R Shpall E Ex vivo expansion of umbilical cord blood Cytotherapy 2005, 7:243-250 10.1080/ 14653240510027172 16081350
32. Pecora AL Stiff P Jennis A Goldberg S Rosenbluth R Price P Goltry KL Douville J Armstrong RD Smith AK Preti RA Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood Bone Marrow Transplant 2000, 25:797-799 10.1038/sj.bmt.1702222 10745268
33. Shpall EJ Quinones R Giller R Zeng C Baron AE Jones RB Bearman SI Nieto Y Freed B Madinger N Hogan CJ Slat-Vasquez V Russell P Blunk B Schissel D Hild E Malcolm J Ward W McNiece IK Transplantation of ex vivo expanded cord blood Biol Blood Marrow Transplant 2002, 8:368-376 10.1053/ bbmt.2002.v8.pm12171483 12171483
34. Jaroscak J Goltry K Smith A Waters-Pick B Martin PL Driscoll TA Howrey R Chao N Douville J Burhop S Fu P Kurtzberg J Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System Blood 2003, 101:5061-5067 10.1182/blood-2001-12-0290 12595310
35. McNiece I Almeida-Porada G Shpall EJ Zanjani E Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential Exp Hematol 2002, 30:612-616 10.1016/ S0301-472X(02)00805-6 12063029
36. Peled T Mandel J Goudsmid RN Landor C Hasson N Harati D Austin M Hasson A Fibach E Shpall EJ Nagler A Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine Cytotherapy 2004, 6:344-355 10.1080/14653240410004916 16146887
37. Brugger W Mocklin W Heimfeld S Berenson RJ Mertelsmann R Kanz L Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin Blood 1993, 81:2579-2584 7683923
38. Gammaitoni L Bruno S Sanavio F Gunetti M Kollet O Cavalloni G Falda M Fagioli F Lapidot T Aglietta M Piacibello W Ex vivo expansion of human adult stem cells capable of primary and secondary hemopoietic reconstitution Exp Hematol 2003, 31:261-270 10.1016/ S0301-472X(02)01077-9 12644024
39. Ivanovic Z Duchez P Dazey B Hermitte F Lamrissi-Garcia I Mazurier F Praloran V Reiffers J Vezon G Boiron JM A clinical-scale expansion of mobilized CD 34+ hematopoietic stem and progenitor cells by use of a new serum-free medium Transfusion 2006, 46:126-131 10.1111/ j.1537-2995.2005.00675.x 16398741
40. Zimmerman TM Lee WJ Bender JG Schilling M Smith SL Van Epps DE Williams SF Clinical impact of ex vivo differentiated myeloid precursors after high-dose chemotherapy and peripheral blood progenitor cell rescue Bone Marrow Transplant 2000, 26:505-510 10.1038/sj.bmt.1702543 11019839
41. Geissler K Yin JA Ganser A Sanz MA Szer J Raghavachar A Hoelzer D Martinez C Taylor K Kanz L To LB Archimbaud E Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia - a randomized, placebo-controlled, double-blind safety and efficacy study Ann Hematol 2003, 82:677-683 10.1007/ s00277-003-0737-7 14530872
42. van den OS de HM Calafat J van der Schoot CE von dem Borne AE A combination of megakaryocyte growth and development factor and interleukin-1 is sufficient to culture large numbers of megakaryocytic progenitors and megakaryocytes for transfusion purposes Br J Haematol 1999, 106:553-563 10.1046/j.1365-2141.1999.01569.x 10460622
43. van den OS von dem Borne AE de HM Influence of medium components on ex vivo megakaryocyte expansion J Hematother Stem Cell Res 2001, 10:193-200 10.1089/152581601750098516 11276373